Neonatal screening for lysosomal storage disorders: feasibility and incidence from a nationwide study in Austria

被引:217
作者
Mechtler, Thomas P. [1 ]
Stary, Susanne [2 ]
Metz, Thomas F. [1 ]
De Jesus, Victor R. [3 ]
Greber-Platzer, Susanne [1 ]
Pollak, Arnold [1 ]
Herkner, Kurt R. [1 ]
Streubel, Berthold [2 ]
Kasper, David C. [1 ]
机构
[1] Med Univ Vienna, Dept Pediat & Adolescent Med, A-1090 Vienna, Austria
[2] Med Univ Vienna, Dept Pathol, A-1090 Vienna, Austria
[3] Ctr Dis Control & Prevent, Newborn Screening & Mol Biol Branch, Atlanta, GA USA
关键词
TANDEM MASS-SPECTROMETRY; DRIED BLOOD SPOTS; FABRY-DISEASE; INBORN-ERRORS; POMPE-DISEASE; NEWBORN; METABOLISM; DIAGNOSIS; ASSAY; REPLACEMENT;
D O I
10.1016/S0140-6736(11)61266-X
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background The interest in neonatal screening for lysosomal storage disorders has increased substantially because of newly developed enzyme replacement therapies, the need for early diagnosis, and technical advances. We tested for Gaucher's disease, Pompe's disease, Fabry's disease, and Niemann-Pick disease types A and B in an anonymous prospective nationwide screening study that included genetic mutation analysis to assess the practicality and appropriateness of including these disorders in neonatal screening panels. Methods Specimens from dried blood spots of 34 736 newborn babies were collected consecutively from January, 2010 to July, 2010, as part of the national routine Austrian newborn screening programme. Anonymised samples were analysed for enzyme activities of acid beta-glucocerebrosidase, alpha-galactosidase, alpha-glucosidase, and acid sphingomyelinase by electrospray ionisation tandem mass spectrometry. Genetic mutation analyses were done in samples with suspected enzyme deficiency. Findings All 34 736 samples were analysed successfully by the multiplex screening assay. Low enzyme activities were detected in 38 babies. Mutation analysis confirmed lysosomal storage disorders in 15 of them. The most frequent mutations were found for Fabry's disease (1 per 3859 births), followed by Pompe's disease (1 per 8684), and Gaucher's disease (1 per 17 368). The positive predictive values were 32% (95% CI 16-52), 80% (28-99), and 50% (7-93), respectively. Mutational analysis detected predominantly missense mutations associated with a late-onset phenotype. Interpretation The combined overall proportion of infants carrying a mutation for lysosomal storage disorders was higher than expected. Neonatal screening for lysosomal storage disorders is likely to raise challenges for primary health-care providers. Furthermore, the high frequency of late-onset mutations makes lysosomal storage disorders a broad health problem beyond childhood.
引用
收藏
页码:335 / 341
页数:7
相关论文
共 44 条
  • [1] [Anonymous], NEWB SCREEN PRET LOW
  • [2] Variable clinical presentation in lysosomal storage disorders
    Beck, M
    [J]. JOURNAL OF INHERITED METABOLIC DISEASE, 2001, 24 : 47 - 51
  • [3] New therapeutic options for lysosomal storage disorders: enzyme replacement, small molecules and gene therapy
    Beck, Michael
    [J]. HUMAN GENETICS, 2007, 121 (01) : 1 - 22
  • [4] Therapy for Lysosomal Storage Disorders
    Beck, Michael
    [J]. IUBMB LIFE, 2010, 62 (01) : 33 - 40
  • [5] Beutler E., 2001, METABOLIC MOL BASES, V3, P3635
  • [6] Reconsidering reproductive benefit through newborn screening: a systematic review of guidelines on preconception, prenatal and newborn screening
    Bombard, Yvonne
    Miller, Fiona A.
    Hayeems, Robin Z.
    Avard, Denise
    Knoppers, Bartha M.
    [J]. EUROPEAN JOURNAL OF HUMAN GENETICS, 2010, 18 (07) : 751 - 760
  • [7] CHACE DH, 1993, CLIN CHEM, V39, P66
  • [8] Pompe Disease in Infants: Improving the Prognosis by Newborn Screening and Early Treatment
    Chien, Yin-Hsiu
    Lee, Ni-Chung
    Thurberg, Beth L.
    Chiang, Shu-Chuan
    Zhang, Xiaokui Kate
    Keutzer, Joan
    Huang, Ai-Chu
    Wu, Mei-Hwan
    Huang, Pei-Hsin
    Tsai, Fuu-Jen
    Chen, Yuan-Tsong
    Hwu, Wuh-Liang
    [J]. PEDIATRICS, 2009, 124 (06) : E1116 - E1125
  • [9] The use of confidence or fiducial limits illustrated in the case of the binomial.
    Clopper, CJ
    Pearson, ES
    [J]. BIOMETRIKA, 1934, 26 : 404 - 413
  • [10] Newborn screening for Pompe disease by measuring acid α-glucosidase activity using tandem mass spectrometry
    Dajnoki, Angela
    Muehl, Adolf
    Fekete, Gyoergy
    Keutzer, Joan
    Orsini, Joe
    Dejesus, Victor
    Zhang, X. Kate
    Bodamer, Olaf A.
    [J]. CLINICAL CHEMISTRY, 2008, 54 (10) : 1624 - 1629